全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

GSTM1 null genotype in COPD and lung cancer: evidence of a modifier or confounding effect?

DOI: http://dx.doi.org/10.2147/TACG.S21517

Keywords: lung cancer, chronic obstructive pulmonary disease, GSTM1, association study, polymorphism, copy number variant

Full-Text   Cite this paper   Add to My Lib

Abstract:

ull genotype in COPD and lung cancer: evidence of a modifier or confounding effect? Original Research (2734) Total Article Views Authors: Young RP, Hopkins RJ, Hay BA, Gamble GD Published Date September 2011 Volume 2011:4 Pages 137 - 144 DOI: http://dx.doi.org/10.2147/TACG.S21517 Robert P Young1,2, Raewyn J Hopkins1, Bryan A Hay1, Gregory D Gamble1 1Schools of Biological Science and Health Sciences, University of Auckland, 2Department of Medicine, Auckland City Hospital, Auckland, New Zealand Background: Studies over the past two decades have reported associations between GSTM1 (glutathione S-transferase mu 1) null genotype and chronic obstructive pulmonary disease (COPD) or lung cancer. However, a modifier or confounding effect from COPD mediating the GSTM1 association with lung cancer has not been previously explored. Aim and methods: This variant was examined in a case-control study of current or former smokers with COPD (n = 669), lung cancer (n = 454), or normal lung function (n = 488). Sex, age, and smoking history were comparable between groups. Results: The GSTM1 null genotype was found to be more frequent in smokers with COPD alone (odds ratio [OR] 1.30, 95% confidence interval [CI] 1.02–1.66, P = 0.031) and lung cancer (OR 1.26, 95% CI 0.96–1.65, P = 0.083) than in matched smokers with normal lung function (62%, 61%, and 56%, respectively). However, when smokers with lung cancer were subgrouped according to the presence of COPD, then the association with all COPD subjects (OR 1.34, 95% CI 1.07–1.70, P = 0.010) and with COPD and lung cancer (OR 1.50, 95% CI 1.06–2.12, P = 0.018) continued to be significant while that with lung cancer only was reduced (OR 1.11, 95% CI 0.78–1.56, P = 0.55). These associations were independent of age, sex, height, lung function, and smoking history. Conclusion: Findings suggest that COPD is an important subphenotype of lung cancer and may underlie previously reported associations with the GSTM1 null genotype.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133